Navigation Links
Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens
Date:2/25/2008

Keane EZ-Access Patcom to Streamline Hospital's Operations and Revenue

Cycle

SAN RAMON, Calif., Feb. 25 /PRNewswire/ -- Keane, Inc., a $1 billion-plus global services firm that specializes in enabling transformation of its clients' business and IT functions, today announced that it has been awarded a contract with Mount Sinai Hospital of Queens, part of New York-based Mount Sinai Medical Center, to install Keane's EZ-Access Patcom and a host of new revenue cycle management and clinical applications that will streamline the hospital's operations and billing.

The installation, which is expected to be complete by the third quarter of 2008, includes Keane's new Executive Dashboard, Enterprise Scheduling and Enterprise CyberQuery (eCQ) products, which will further streamline the hospital's billing and operations, as well as Keane's Data Repository, enabling physicians to access patient information collected and processed from disparate systems from a single entry point.

"Our continued partnership with Keane will enable us to upgrade many of the critical information technology systems that serve as the operational backbone of our facility," said Caryn A. Schwab, Executive Director of Mount Sinai Hospital of Queens. "We are committed to leveraging the newest technological advancements throughout the hospital to create the most favorable experience for our patients, and the most efficient work environment for our staff."

"We are delighted to continue working with Keane on a number of upgrades to improve the way we collect, manage and access critical patient billing and clinical information throughout the facility," said Jack Abuin, Director of IT for Mount Sinai Hospital of Queens. "Our upgrade to EZ-Access Patcom will provide a fully-customizable interface that is accessible through conventional internet browser technologies, and will enable us to significantly streamline workflow processes. In addition
'/>"/>

SOURCE Keane, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
2. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
3. Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01 Per Share
6. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
7. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
8. Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
9. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
10. Immucor Announces Record Fiscal First Quarter Revenues
11. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)... Colo., Nov. 21 Heska Co...ll present at the New York Society of,Security An...onference on,December 2, 2008 at 1177 Avenue of t...ntation is scheduled to begin at 9:35 a.m. Eastern...able via live webcast and for two weeks,following...
(Date:11/21/2008)...rchers remain cautious about future antibiotic res..., Nov. 21 (HealthDay News) -- People with moderate...COPD) may be able to reduce the frequency of exace...ntibiotic, a new report says. , The study, pub...rican Journal of Respiratory and Critical Care Med...
(Date:11/21/2008)...Nov. 21 The University... beginning of a collaborative effort to eradicate ...r Breast Cancer Awareness and Research of the Amer...Lady of the United States, and Vivian Fernandez de...ining M. D. Anderson in the initiative are the U.S...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...transvaginal ultrasound scans can do away with inv... tests, used for determining// a woman’s success r...Kwee from Vrije Universiteit Medical Center in Ams...e ovaries of women subjects in an IVF program. ...
...re consuming very little of vegetables and fruits ...d other ailments//. This was disclosed by Heidi Bl... Blanck found that 32.6% of the respondents had fr...umed vegetables thrice or more than thrice per day...
...health caused by an unintentional injury or new ch...likely to have difficulty// obtaining recommended ...declines in short-term health, according to a stud...nstitute, Washington, D.C., presented the results ...
...rary of Science) suggests that computers could gue...lating// the wishes of a terminally sick patient. ...tumbled upon this finding while he was analyzing t...ne on the course of action involving a critically ...
Other Medicine News:Health News:Cheaper and Quicker Alternative to Ovarian Reserve Tests 2Health News:Uninsured Often Receive Less Medical Care 2
(Date:11/19/2008)...on Payment from Roche- , , MONTVALE, N.J., ...ticals Corp. (Nasdaq: MEMY ) today announced tha...e 2 trial of R3487/MEM 3454, its lead alpha-7 nico...sociated with schizophrenia (CIAS). The Company h...riggering a $5.0 million payment from its partner ...
(Date:11/18/2008)...v. 18 Forty-two leading...vember national forum to consider cutting-edge inn...nd national economy from outbreaks of dangerous zo..., , Among those innovations: , , , ...tchen table that detects highly contagious and dan...
(Date:11/13/2008)...ests Nutritional Supplements Prior to Surgery, AR...ire/ -- Identifying,malnutrition before surgery in...ing will significantly decrease surgical complicat...ty and boost patient energy levels,according to a...tructive,Surgery(R), the official medical journal ...
(Date:11/12/2008)...o and LOD, Israel, November 12 Sur...r, NY indicated that,patient-specific CTA data can...Mentor(TM), Simbionix US) with high face validity....n improved the operative flow,increased patient s...overall operative and fluoroscopy time and the amo...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 1Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 1URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 3URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 4URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 5New Generation Biofuels Set to Join Russell Microcap Index 6178 1New Generation Biofuels Set to Join Russell Microcap Index 6178 2New Generation Biofuels Set to Join Russell Microcap Index 6178 3Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 1Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 2Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 3Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 4
...sitive Phase IIa Clinical,Trial Results, First cli... Key,Product in AM-Pharma,s Pipeline , BUNNIK, The...pharmaceutical company developing novel therapeuti...today announced the positive,clinical results of i...atients with ulcerative colitis, a chronic and rel...
...nc. (NASDAQ:INSM), a ,biopharmaceutical company fo... the treatment of metabolic diseases with unmet,m...t at this,week,s C.E. Unterberg, Towbin (CEUT) Eme...City. , The conference, to be held at the Manda...m Tuesday, July 10th through Thursday,July 12th. ...
Other Medicine Technology:AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
...erior Chamber Lenses: The Bausch & Lomb PMMA Poste... used for primary implantation for the visual corr...lder where a cataractous lens has been removed by ... intended to be placed in the ciliary sulcus or ca...
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Multipiece PMMA IOL - Sulcus Fixation.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Medicine Products: